Variant report
Variant | esv2645094 |
---|---|
Chromosome Location | chr3:55971596-55973175 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568686555 | chr3:55971611-55971612 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150430032 | chr3:55971618-55971619 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs186476181 | chr3:55971621-55971622 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs556370141 | chr3:55971654-55971655 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs369148944 | chr3:55971677-55971678 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553071324 | chr3:55971763-55971764 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs375449248 | chr3:55971814-55971815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572881804 | chr3:55971833-55971834 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs191354848 | chr3:55971843-55971844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs561917219 | chr3:55971852-55971853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575489881 | chr3:55971875-55971876 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs114565662 | chr3:55971920-55971921 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs372644887 | chr3:55971949-55971950 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs563344457 | chr3:55972030-55972031 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532343356 | chr3:55972067-55972068 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs138178057 | chr3:55972083-55972084 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs182823008 | chr3:55972118-55972119 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs528562123 | chr3:55972139-55972140 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530550438 | chr3:55972145-55972146 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548543716 | chr3:55972167-55972168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs141208142 | chr3:55972223-55972224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs537349901 | chr3:55972377-55972378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551271103 | chr3:55972378-55972379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535607343 | chr3:55972379-55972380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs370311410 | chr3:55972391-55972392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145025802 | chr3:55972399-55972400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539475606 | chr3:55972418-55972419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186171668 | chr3:55972472-55972473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs572899171 | chr3:55972533-55972534 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs554975178 | chr3:55972541-55972542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs190444659 | chr3:55972550-55972551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs138746149 | chr3:55972555-55972556 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs544121399 | chr3:55972657-55972658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs115971112 | chr3:55972660-55972661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533950365 | chr3:55972669-55972670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs555618648 | chr3:55972683-55972684 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs148039127 | chr3:55972685-55972686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559316262 | chr3:55972696-55972697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs376503756 | chr3:55972720-55972721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567541642 | chr3:55972772-55972773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs528615763 | chr3:55972790-55972791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs141662309 | chr3:55972797-55972798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs150534362 | chr3:55972825-55972826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs116349498 | chr3:55972841-55972842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs183412588 | chr3:55972901-55972902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs538168236 | chr3:55972919-55972920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs571191786 | chr3:55972921-55972922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs201923219 | chr3:55972971-55972972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12107629 | chr3:55972977-55972978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546660491 | chr3:55972978-55972979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Breast cancer | 21785460 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cancer | 20164919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:55969600-55991600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr3:55970800-55972200 | Enhancers | Stomach Mucosa | stomach |
3 | chr3:55971800-55972200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |